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ABSTRACT
Objective To assess trends in place of death for 
children with a life- limiting condition and the factors 
associated with death at home or hospice rather than 
hospital.
Design Observational cohort study using linked 
routinely collected data.
Setting England.
Patients Children aged 0–25 years who died between 
2003 and 2017.
Main outcome measures Place of death: hospital, 
hospice, home. Multivariable multinomial logistic 
regression models.
Results 39 349 children died: 73% occurred in hospital, 
6% in hospice and 16% at home. In the multivariable 
models compared with dying in a hospital: neonates 
were less likely, and those aged 1–10 years more 
likely, than those aged 28 days to <1 year to die in 
hospice. Children from all ethnic minority groups were 
significantly less likely to die in hospice, as were those 
in the most deprived group (RR 0.8, 95% CI 0.7 to 0.9). 
Those who died from 2008 were more likely than those 
who died earlier to die in a hospice.
Children with cancer (RR 4.4, 95% CI 3.8 to 5.1), 
neurological (RR 2.0, 95% CI 1.7 to 2.3) or metabolic 
(RR 3.7, 95% CI 3.0 to 4.6) diagnoses were more 
likely than those with a congenital diagnosis to die in a 
hospice.
Similar patterns were seen for clinical/demographic 
factors associated with home versus hospital deaths.
Conclusions Most children with a life- limiting 
condition continue to die in the hospital setting. Further 
research on preferences for place of death is needed 
especially in children with conditions other than cancer. 
Paediatric palliative care services should be funded 
adequately to enable equal access across all settings, 
diagnostic groups and geographical regions.
INTRODUCTION
Although deaths in childhood have been decreasing, 
there are still 4500 infants and children who die 
in England and Wales every year1 and approxi-
mately 50% of deaths in children2 are for children 
with a life- limiting or life- threatening condition. 
Access to palliative and end- of- life care are there-
fore important components of paediatric health 
services.3
Palliative care services for children and young 
people in the UK have developed locally with heavy 
reliance on individual clinicians and third sector 
organisations such as children’s hospices.3 That 
ad hoc provision means delivery of palliative care 
is often ‘inconsistent and incoherent’.4 The recent 
NICE guidelines5 and quality standards of providing 
care6 include: ‘Infants, children and young people 
approaching the end of life and being cared for at 
home have 24 hour access to both children’s nursing 
care and advice from a consultant in paediatric 
palliative care’. Currently in England, while there 
are more than 50 children’s hospices, there are even 
tertiary children’s hospitals, including oncology 
centres, without a paediatric palliative care service.
Place of death has been used in policy docu-
mentation as a measure of quality of palliative or 
end- of- life care in developed countries such as 
the UK.7 The assumption that everyone wants to 
die at home has been contested in both children’s 
and adult palliative care in recent years.8 9 A recent 
review has concluded that ‘Most parents, children, 
and providers prefer home death and the long- term 
outcomes for parents (even 6–8 years after the death 
of their child) may be better when their child died 
at home’ but the authors also acknowledge that not 
all parents prefer a home death and the evidence 
is often from small studies.10 However, at a popu-
lation level, if we are truly able to offer choice of 
place of care at the end of life then we should see 
a spread between the possible places of death. One 
of the aims of recent NHS England service spec-
ification for palliative care is that ‘more children 
and young people will achieve their preferred place 
of care at the end of their lives’. A national study 
showed that children who had palliative care input 
were eight times as likely as those without palliative 
What is already known on this topic?
 ► Place of death is used as a quality measure of 
end- of- life care.
 ► More children die at home or in hospice setting 
if they have palliative care input.
 ► The current evidence states that most parents, 
children and providers prefer home death.
What this study adds?
 ► The vast majority of children with a life- limiting 
condition continue to die in the hospital setting.
 ► Children with a cancer diagnosis are much more 
likely to die at home or in hospice than children 
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care input to die in the community rather than in hospital.11 
Therefore, the distribution of deaths between hospital, home 
and hospice may provide an indication of the degree to which 
families are able to access palliative care.
Aims and objectives
This study aims to assess the trends in place of death for children 
who died with a life- limiting condition in England from 2003 to 
2017 and the clinical and demographic factors which are associ-
ated with death at home or hospice rather than hospital.
METHODS
Data sources
Linked individual- level inpatient Hospital Episode Statistics 
(HES) and Office for National Statistics (ONS) death records 
were obtained from NHS Digital. These two data sets were 
linked by NHS Digital based on National Health Service 
number, gender date of birth and postcode.12 13 Children and 
young people with a life- limiting condition were identified by 
matching recorded diagnostic codes in inpatient records against 
the previously developed ICD-10 coding framework14 (online 
supplemental table 1), for individuals aged 0–25 years (1 January 
2000 to 31 December 2017).
Data management
Place of death was categorised as hospital, hospice, home, other 
and missing based on the recorded address of death in the ONS 
death certificate data. The ‘other’ category included deaths at 
respite care centres, nursing homes, deaths outside the home (eg, 
in a park or school). Deaths where the street address was not 
present were recorded as missing.
The year of death was assigned from the ONS death certificate 
date of death and the sex was assigned as the most commonly 
recorded sex from the HES data.
Age of death at last birthday was calculated by subtracting date 
of birth (HES record) from date of death (ONS record). Those 
who had died in the neonatal period (<28 days) were flagged on 
the death record. Seven age groups were created: neonate <28 
Table 1 Demographic characteristics of children and young people with a life- limiting condition who died*
Hospital Hospice Home Other or missing† Total
n % n % n % n % n
Total 28 753 73 2453 6 6269 16 1874 5 39 349
Sex
  Male 15 846 73 1332 6 3579 16 1066 5 21 823
  Female 12 885 74 1121 6 2689 15 750 4 17 445
Age group at death
  Neonate (<28 days) 9511 97 163 2 171 2 9846
  28 days to 1 year 5586 71 380 5 614 8 1301 17 7881
  1–5 years 3498 68 488 10 1063 21 79 2 5128
  6–10 years 1554 57 295 11 819 30 48 2 2716
  11–15 years 1772 59 302 10 856 29 68 2 2998
  16–20 years 3010 63 347 7 1266 27 138 3 4761
  21–25 years 3822 63 478 8 1480 25 239 4 6019
Ethnic group
  White 18 017 69 1973 8 5030 19 949 4 25 969
  Black 1937 83 73 3 187 8 136 6 2333
  Pakistani 2521 84 99 3 301 10 93 3 3014
  Indian 888 81 39 4 117 11 47 4 1091
  Bangladeshi 544 85 16 2 61 9 22 3 643
  Mixed/Chinese/other 2393 78 167 5 340 11 175 6 3075
Region
  North- East 1227 71 60 4 392 23 58 3 1737
  North- West 4100 75 292 5 889 16 211 4 5492
  Yorkshire and Humber 2745 71 361 9 663 17 122 3 3891
  East Midlands 2212 75 153 5 512 17 87 3 2964
  West Midlands 3270 75 291 7 661 15 164 4 4386
  East of England 2435 68 295 8 710 20 120 3 3560
  London 4874 77 267 4 775 12 423 7 6339
  South- East 3631 69 457 9 985 19 219 4 5292
  South- West 2136 68 250 8 626 20 119 4 3131
Deprivation category
  Category 1 (least deprived) 3179 66 431 9 1071 22 156 3 4837
  Category 2 3866 68 454 8 1186 21 220 4 5726
  Category 3 4851 70 495 7 1287 19 294 4 6927
  Category 4 6096 74 507 6 1302 16 325 4 8230
  Category 5 (most deprived) 7851 78 533 5 1339 13 409 4 10 132
*Those with missing deomgraphics are not presented due to small numbers.
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days, 28 days–1 year, 1–5 years, 6–10 years, 11–15 years, 16–20 
years and 21–25 years.
Self- reported ethnicity for each hospital episode was coded 
according to the 16 census groups;15 to prevent small numbers, 
these groups were collapsed into six ethnic groups as follows 
with the most commonly recorded ethnicity (from the six 
collapsed groups) assigned to each individual:
 ► White (white: British, white: Irish, other white)
 ► Black (black or black British: black Caribbean, black or black 
British: black African, black or black British: other black)
 ► Indian (Asian or Asian British: Indian)
 ► Pakistani (Asian or Asian British: Pakistani)
 ► Bangladeshi (Asian or Asian British: Bangladeshi)
 ► Other (Chinese, mixed or other)
The last known government office region of residence was 
assigned using the HES and ONS data for each individual.
An Index of Multiple Deprivation (IMD2010) Score16 was 
assigned to each individual based on last known lower super 
output area (LSOA) of residence. LSOAs are small geographical 
areas with a population from 1000 to 3000 individuals. Five 
population- weighted categories were created (category 1—least 
deprived) based on the IMD Scores with approximately 20% of 
the population living in each category.
The life- limiting condition diagnoses were grouped according 
to 11 diagnostic groups (neurology, haematology, oncology, meta-
bolic, respiratory, circulatory, gastrointestinal, genitourinary, 
perinatal, congenital and other).14 The most common diagnostic 
group across all inpatient records for each individual was calcu-
lated with ties resolved by giving preference to later diagnoses.
Analysis
To avoid missing data issue at the start of the study time period, 
children were included in the analyses 2003 onwards.
Temporal trends in place of death were plotted as a visual 
assessment of change over time. Place of death was described by 
sex, age group, ethnicity, government office region, deprivation 
category and main diagnostic group.
The association between the place of death and key clinical 
(diagnostic group) and demographic (age, sex, ethnic group, 
deprivation status and region) variables was assessed using multi-
variable multinomial logistic regression modelling comparing 
hospital death to both home and hospice deaths. Year of death 
was included in three equal epochs: 2003–2007, 2008–2012 
and 2013–2017.17
All data manipulation was undertaken using Microsoft SQL 
server and statistical analysis using STATA V.15 (StataCorp, 
Collage Station, Texas, USA). Statistical significance was assumed 
at p≤0.05 (two- sided).
RESULTS
Cohort
The total cohort of children with a life- limiting condition who 
had died from 2000 to 2017 was 53 518. After removal of those 
not resident in England (n=1512) and those who died before 
2003 or after 2017 (n=7853) and those who died >25 years 
(n=4804), the final cohort for analyses was 39 349.
Place of death
Overall 73% of deaths occurred in hospital, 6% in hospice and 
16% at home. Five per cent died elsewhere or were missing place 
of death (table 1).
The percentage of deaths in hospital remained relatively 
static at just over 70% of deaths (figure 1). The percentage of 
children who died at home remained relatively static at around 
15%–16%. This was in contrast to deaths in hospices which rose 
from 5% to 8% during the period of this study.
Place of death varied considerably by age with 97% of neonates 
and 71% of those aged 28 days to 1 year dying in hospital and 
only 2% and 8%, respectively, dying at home (table 1). The 
percentage of children dying at home peaks at 30% in those aged 
6–10 years. Deaths in hospices were also most common, at 11%, 
in the 6–10 years age group.
Figure 1 Trends in place of death of children and young people with a 
life- limiting condition in England from 2003 to 2017. LLC, life- limiting or 
life- threatening condition.
Table 2 Clinical characteristics of children and young people with a life- limiting condition who died
Hospital Hospice Home Other or missing* Total
Cancer 3515 44 1075 14 3224 41 100 1 7914
Metabolic conditions 830 61 179 13 306 23 36 3 1351
Neurological conditions 3387 68 458 9 965 19 184 4 4994
Other conditions 530 71 73 10 92 12 51 7 746
Circulatory conditions 8276 81 425 4 917 9 621 6 10 239
Genitourinary conditions 1775 82 44 2 196 9 160 7 2175
Respiratory conditions 1766 82 69 3 243 11 86 4 2164
Haematological conditions 559 85 13 2 63 10 20 3 655
Congenital conditions 1074 86 20 2 105 8 46 4 1245
Gastrointestinal conditions 475 88 11 2 25 5 30 6 541
Perinatal conditions 6566 90 86 1 133 2 540 7 7325
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A lower percentage of white children died in hospital (69%) 
when compared with the other ethnic groups where between 
78% (Chinese/mixed/other) to 85% (Bangladeshi) died in 
hospital.
The highest percentage of deaths in hospital were in London 
(77%) with the lowest in the South- West (69%). Yorkshire and 
the Humber and the South- East had the highest percentage 
of hospice deaths (9%) and the North- East the lowest (4%). 
Table 3 Multivariable multinomial logistic models (n=34 425)
Hospice versus hospital Home versus hospital
RR 95% CI P value RR 95% CI P value
Age at death
  Neonate 0.4 0.3 0.5 0.2 0.2 0.3
  28 days to 1 year REF REF
  1–5 years 1.1 0.9 1.3 <0.001 1.6 1.4 1.8 <0.001
  6–10 years 1.1 0.9 1.3 <0.001 2.2 1.9 2.5 <0.001
  11–15 years 1.0 0.8 1.2 0.002 2.0 1.7 2.3 <0.001
  16–20 years 0.7 0.6 0.8 0.242 1.7 1.5 1.9 <0.001
  21–25 years 0.8 0.6 0.9 0.956 1.6 1.4 1.8 <0.001
Sex
  Male REF REF
  Female 1.0 0.9 1.1 0.286 0.9 0.9 1.0 0.104
Ethnic group
  White REF REF
  Black 0.5 0.4 0.6 <0.001 0.5 0.4 0.6 <0.001
  Pakistani 0.3 0.3 0.4 <0.001 0.5 0.5 0.6 <0.001
  Indian 0.5 0.3 0.6 <0.001 0.6 0.5 0.7 <0.001
  Bangladeshi 0.3 0.2 0.6 <0.001 0.6 0.4 0.8 <0.001
  Mixed/Chinese/other 0.7 0.6 0.8 <0.001 0.6 0.5 0.7 <0.001
  Missing 0.6 0.5 0.8 <0.001 0.7 0.6 0.9 <0.001
Deprivation category
  Category 1—least deprived REF REF
  Category 2 1.0 0.8 1.1 0.529 1.0 0.9 1.1 0.952
  Category 3 0.9 0.8 1.0 0.145 0.9 0.8 1.0 0.147
  Category 4 0.9 0.8 1.0 0.054 0.9 0.8 0.9 0.01
  Category 5—most deprived 0.8 0.7 0.9 0.003 0.8 0.7 0.8 <0.001
Government office region
  London REF REF
  North- East 0.7 0.6 1.0 0.047 1.7 1.4 1.9 <0.001
  North- West 1.2 01.0 1.4 0.062 1.2 1.1 1.4 0.002
  Yorkshire and Humber 2.3 1.9 2.7 <0.001 1.4 1.2 1.6 <0.001
  East Midlands 1.0 0.8 1.3 0.933 1.1 1.0 1.3 0.118
  West Midlands 1.6 1.4 12.0 <0.001 1.2 1.1 1.4 0.003
  East of England 1.8 1.5 2.1 <0.001 1.4 1.2 1.6 <0.001
  South- East 1.8 1.5 2.2 <0.001 1.3 1.2 1.5 <0.001
  South- West 1.7 1.4 2.1 <0.001 1.4 1.3 1.6 <0.001
Year of death
  2003–2007 REF REF
  2008–2012 1.5 1.3 1.6 <0.001 1.1 1.04 1.2 0.003
  2013–2017 1.7 1.5 1.9 <0.001 1.2 1.07 1.3 0.003
Main diagnostic group
  Congenital conditions REF REF
  Circulatory conditions 0.3 0.2 0.5 <0.001 0.6 0.5 0.7 <0.001
  Gastrointestinal conditions 0.4 0.2 0.7 0.005 0.3 0.2 0.5 <0.001
  Genitourinary conditions 0.4 0.3 0.6 <0.001 0.6 0.5 0.7 <0.001
  Haematological conditions 0.4 0.2 0.7 0.003 0.6 0.5 0.8 0.004
  Metabolic conditions 3.7 3.0 4.6 <0.001 2.1 1.8 2.5 <0.001
  Neurological conditions 2.0 1.7 2.3 <0.001 1.3 1.2 1.5 <0.001
  Cancer 4.4 43.8 5.1 <0.001 4.0 3.6 4.4 <0.001
  Other conditions 2.4 1.8 3.1 <0.001 1.2 0.9 1.5 0.134
  Perinatal conditions 0.3 0.3 0.4 <0.001 0.4 0.3 0.5 <0.001
  Respiratory conditions 0.6 0.4 0.8 0.002 0.7 0.6 0.8 <0.001
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Conversely the highest percentage of home deaths was also in 
the North- East (23%) and the lowest in London (12%).
There is a linear trend with deprivation, the more deprived 
being more likely to die in hospital.
Table 2 shows the distribution of place of death by diagnostic 
category. The percentage of children with cancer who died in 
hospital was 44% with the next lowest metabolic at 61%. Home 
deaths were also highest among children who had cancer (41%) 
and were lowest among those who had perinatal conditions 
(2%). Children with cancer (14%), metabolic conditions (13%), 
other conditions (10%) or neurological conditions (9%) had the 
highest percentage of hospice deaths.
The results of the multivariable multinomial logistic regres-
sion model comparing dying at home or in a hospice compared 
with dying in hospital are shown in table 3. The reference group 
for comparison throughout this section is hospital.
Hospice versus hospital: Neonates were less likely than those 
aged 28 days to <1 year to die in hospice and those aged 1–10 
years were more likely to die in a hospice than those aged 28 
days to 1 year. However, those aged 11–25 years were no more 
likely than the those aged 28 days to <1 year to die in a hospice.
Children from all the ethnic minority groups were significantly 
less likely to die in hospice with children of Bangladeshi origin 
being the least likely to die in a hospice (RR 0.3, 95% CI 0.2 to 
0.6) compared with white children. Those in the most deprived 
group were also less likely to die in a hospice compared with the 
least deprived (RR 0.8, 95% CI 0.7 to 0.9). There were some 
geographical differences, with those who died in Yorkshire and 
Humber more likely than those in London to die in a hospice 
(RR 2.3, 95% CI 1.9 to 2.7). Those in the North- East were less 
likely than those in London to die in a hospice (RR 0.7, 95% CI 
0.6 to 1.00).
Those who died after 2008 were more likely than those who 
died before 2008 to die in a hospice.
Children with a cancer (RR 4.4, 95% CI 3.8 to 5.1), neurolog-
ical (RR 2.0, 95% CI 1.7 to 2.3) or metabolic (RR 3.7, 95% CI 
3.0 to 4.6) diagnosis were more likely than those with a congen-
ital diagnosis to die in a hospice.
There are some similarities in the home versus hospice compo-
nent of the model for sex, ethnic group, deprivation and trends 
over time. The key differences in this comparison were that all 
age groups over 1 year were more likely than the 28 days to <1 
year old group to die at home. Children from all other regions 
were more likely than those living in London to die at home 
compared (including the North- East, RR 1.7, 95% CI 1.4 to 1.9, 
in contrast to the results for hospice compared with hospital).
DISCUSSION
The majority of children with a life- limiting condition in England 
continue to die in a hospital setting. There is some evidence of 
an increase in hospice deaths since the government report ‘Better 
Care, Better Lives’ in 200818 but there is still a relatively small 
number of deaths (<200) in hospices each year. The most recent 
national children’s hospice data collection showed that only 
21% of their caseload who died, died in the hospice.19
A higher proportion died in hospital in the present study than 
in studies from other countries20 21 which may not be surprising 
given the different models of provision of palliative care and 
funding of healthcare systems across the world. The proportion 
of deaths at home are similar to figures from the USA (10.1% in 
1989 rising to 18.2% in 2003)22 and Portugal (19.4%).23
Palliative care input has been associated with more children 
dying outside the hospital; a national study from England and 
Wales of 7709 children who died after being discharged from 
paediatric intensive care units showed that children who had 
palliative care recorded at the time of discharge were eight times 
more likely to die in the community than children who were not 
referred to palliative care.11 Likewise the study by Chang et al, 
showed that those who had palliative care were less likely to die 
in hospital.20 A study from Germany showed that of children 
who received specialist paediatric palliative care, 84% died at 
home with 96% in their preferred place.24 The general consensus 
among studies to date is that home is the preferred place of 
death, although not all families prefer home deaths; preferences 
vary over time and the research base consists of small studies 
which were prone to selection bias.10
Children with cancer were much more likely than other chil-
dren to die at home or in a hospice. In England, children with 
cancer are treated and managed under a different model of care 
with palliative care being provided by specialists, including the 
paediatric oncology outreach nurses in most principal treatment 
centres.25 A recent national study showed that from 1993 to 
2014, among children who died from cancer in England, those 
dying at home remained static at approximately 40%; hospital 
deaths decreased slightly from >50% to 45% and hospice deaths 
increased from 6% to 13%.26 An international study21 high-
lighted large variations in place of death between countries and 
that children with conditions other than cancer were less likely 
to die at home.
Age has been shown in several studies to be associated with 
dying at home with infants less likely than older children to die 
outside hospital.22 27 The predominance of hospital death in the 
neonatal group may highlight the unpredictability of their prog-
nosis and the additional challenges of offering choice of place of 
death in neonatal care.28
This study highlighted the differences in place of death for 
children from a minority ethnic group. This has been shown in 
other studies.20 26 There is little evidence on preferences of place 
of care in these populations and differences could possibly be 
due to access to healthcare services, divergent cultural attitudes 
or differing levels of financial or social support within a patient’s 
family or social network.22 Importantly, services must be flexible 
enough to meet the needs of all children and their families.17 29
Strengths and limitations
This study used a whole population data set to identify children 
with a life- limiting condition and national death registration 
records. There can be delays in the registration of deaths for 
children if the coroner is involved so the recent years of data 
may be incomplete.
It was not possible to identify those children who had and had 
not received palliative care prior to death. There were no data 
on preferred place of death available for this cohort of children.
CONCLUSIONS
Despite small increases in hospice deaths over the last 15 years 
the vast majority of children with a life- limiting condition die in 
the hospital setting. Further research is needed on preferences 
for place of death especially in children with conditions other 
than cancer. Paediatric palliative care services should be funded 
adequately to enable equal access across all settings, diagnostic 
groups and geographical regions.
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Supplementary Table 1 
 
: ICD-10 diagnostic coding framework used to identify and categorise children with life-limiting 
conditions.  
Diagnostic Group ICD-10 Numbers 
Neurology 
A17 A810 A811 F803 F842 G10 G111 G113 G12 G20 G230 G238 G318 G319 
G35 G404 G405 G600 G601 G702 G709 G710 G711 G712 G713 G800 G808 
G823 G824 G825 G934 G936 G937 
Haematology B20 B21 B22 B23 B24 D561 D610 D619 D70 D761 D81 D821 D83 D891 
Oncology C D444 D48 (Central Nervous System: C70,C71,C72, D33, D43) 
Metabolic E310 E348 E702 E71 E72 E74 E75 E76 E77 E791 E830 E880 E881 
Respiratory E84 J841 J96 J984 
Circulatory I21 I270 I42 I613 I81 
Gastrointestinal K550 K559 K72 K74 K765 K868 
Genitourinary N17 N18 N19 N258 (Early stage (1-3) renal:N181, N182, N183) 
Perinatal 
P101 P112 P210 P285 P290 P293 P350 P351 P358 P371 P524 P525 P529 
P832 P912 P916 P960 
Congenital 
Q000 Q01 Q031 Q039 Q040 Q042 Q043 Q044 Q046 Q049 Q070 Q200 Q203 
Q204 Q206 Q208 Q213 Q232 Q218 Q220 Q221 Q224 Q225 Q226 Q230 Q234 
Q239 Q254 Q256 Q262 Q264 Q268 Q282 Q321 Q336 Q396 Q410 Q419 Q437 
Q442 Q445 Q447 Q601 Q606 Q614 Q619 Q642 Q743 Q748 Q750 Q772 Q773 
Q774 Q780 Q785 Q792 Q793 Q804 Q81 Q821 Q824 Q858 Q860 Q870 Q871 
Q872 Q878 Q91 Q920 Q921 Q924 Q927 Q928 Q932 Q933 Q934 Q935 Q938 
Q952  
Other H111 H498 H355 M313 M321 M895 T860 T862 Z515 
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